Skip to content

Social support for children living with HIV is a key determinant of treatment success, Senegal study shows

GPE/Chantal Rigaud. Creative Commons licence.

Community support for caregivers helps children living with HIV achieve viral suppression

Dr Patrick Oyaro presenting at INTEREST 2023.

The paediatric drug pipeline should include improvements to current HIV treatment, long-acting formulations and antibodies

UNDP South Sudan/Brian Sokol. Creative Commons licence. Image for illustrative purposes only.

Nevirapine treatment linked to poorer cognitive development in children with HIV

Image by Elizabeth Glaser Pediatric AIDS Foundation/DFID - UK Department for International Development. Creative Commons licence. Image is for illustrative purposes only.

Package of person-centred care improves viral suppression for young people living with HIV in Kenya and Uganda

Image by Morgana Wingard/Global Fund Advocates Network. Creative Commons licence.

Six-country study shows dolutegravir-based treatment is highly effective in children and adolescents

Young people at a Baylor International Pediatric AIDS Initiative Centre in Tanzania. Photo with permission, Baylor College of Medicine Children's Foundation, Tanzania.

South Africa could be among the last to rollout child-friendly dolutegravir

Dispersible antiretrovirals. Image: Drugs for Neglected Diseases initiative.

High levels of infant resistance to abacavir and tenofovir in Namibia

Image by Cordelia Persen. Creative Commons licence.

Top 5 HIV treatment stories from CROI 2022

Professor Samir Gupta (top right) presenting a study on lenacapavir at CROI 2022.